NCBiotech News

Raleigh's Micell Technologies has drawn the attention--and a $15 million investment--from global medical technologies giant St. Jude Medical.

Micell, which employs 10 people, is developing coating systems that can be used to deliver drugs via medical devices such as the wire-mesh stents now in routine use to open clogged arteries in the heart.

Opportunities in marine biotechnology, biofuels, and agricultural biotechnology are among the hopeful targets of North Carolina Public Television special.

The hour-long program aired Sept. 2 on UNC-TV.

Students from the life-science programs at UNC-Chapel Hill and Duke University crowded into the Biotechnology Center today to learn how to make the challenging leap from an academic environment to an industry job.

The attendees got to network with post doctorates currently in the Center's Industrial Fellowship program and mingle with top industry executives from North Carolina's biotechnology companies.

The academic and company laboratories in and around the North Carolina Research Campus will need workers trained in a range of specific techniques.

Enter Rowan-Cabarrus Community College, which today broke ground on a 62,000-square-foot training facility. The community turned out in force for the ceremony, two blocks from the Research Campus' famed core-laboratory facility.

All service businesses are hurting for revenues these days, including Contract Research Organizations.

Yonnie Butler, the Biotechnology Center's business development director, had some insight that he thought would help. This issue of Tablets & Capsules contains his advice.

Interested in the promise of biotechnology, but not sure how to bring it to the classroom?

Been teaching science a long time, but looking for some new ideas?

Sign up for one of our annual summer teacher workshops. The week-long classes are held across the state and are open to North Carolina teachers.

A $50 registration fee holds your place, and most workshops pay a stipend and give you access to free laboratory supplies for the coming year.

More Information

When our economy recovers, it's a good bet that the biotechnology sector will be one of those sectors leading the way.

Merck enters an agreement to buy clinical-stage startup VelosBio for $2.75 billion.

Syneos Health, one of the biggest contract service providers in the sector is getting even bigger through the acquisition of Synteract.

For more than 30 years, Genova Diagnostics has been quietly growing its clinical laboratory services from its headquarters in Asheville, evolving into the significant new world of precision health services.

Innovate Biopharmaceuticals, a clinical-stage biotechnology company based in Raleigh, has submitted an application to the U.S. Food and Drug Administration (FDA) seeking orphan drug designation for an oral therapy to treat pediatric ulcerative colitis.

Two Kansas startup companies won the top prizes at NCBiotech's two-day 2017 Ag Biotech Entrepreneurial Showcase in Durham.

A dozen ag biotech startups pitched their wares this week to a receptive crowd at the North Carolina Biotechnology Center’s 2017 Ag Biotech Entrepreneurial Showcase at the Cotton Room in Durham.

Five of the Piedmont Triad region’s most successful individuals and organizations working in the biosciences have been honored with 2017 Excellence Awards at Triad BioNight, a biennial celebration of the region’s life science sector organized by the Piedmont Triad Office of the North Carolina Biotechnology Center.

Melissa Price, Ph.D., Heat Bio's vice president of clinical development and regulatory affairs. -- Courtesy of Heat Biologics